Ahmed A, Hickey SM, Ehrett S, et al. Cerebrospinal fluid values in the term neonate. Pediatr Infec Dis J. 1996;15:298-303.
Alfonso I, Hahn JS, Papazian O, et al. Bilateral tonic-clonic epileptic seizures in non-benign familial neonatal convulsions. Pediatr Neurol. 1997:16:249-251.
Alfonso I, Perea A, Paez JC, et al. Intravenous valproic acid dose in neonates. Epilepsia. 1999;40,Suppl 7:143.
Alfonso I, Alvarez LA, Gilman J, et al. Intravenous Valproate Dosing in Neonates. 2000;15: in press.
Alvarez LA, Yamamoto T, Wong B, et al. Miller-Dieker syndrome: a disorder affecting specific pathways of neuronal migration. Neurology. 1986;36:489-493.
Barkovich AJ. Congenital Malformation of the Brain and Skull. In: Pediatric Neuroimaging. New York, NY: Raven Press; 1995:177-275.
Barr PA, Buetiker VE, Antony JH. Efficacy of lamotrigine in refractory neonatal seizures. 1999;20:161-163.
Berry PL, Belsha CW. Hyponatremia. Pediatr Clin N Am. 1990;37:351-363.
Browne TR, Holmes GL. Handbook of Epilepsy. Philadelphia, Penn: Lippincott-Raven; 1997.
Conley SB. Hypernatremia. Pediatr Clin N Am. 1990;37:365-371.
Davies PA, Rudd PT. Neonatal Meningitis. London, England: Mac Keith Press; 1994.
De Vivo DC, Trifiletti RR, Jacobson RI, et al. Defective glucose transport across the blood-brain barrier as cause of persistent hypoglucorrhagia, seizures and developmental delay. N Engl J Med. 1991;325:703-709.
Donnai D, Winter RM. Congenital Malformation Syndromes. London, England: Chapman & Hall Medical; 1995:235-253.
ElDahr SS, Chevalier RL. Special needs of the newborn infant in fluid therapy. Pediatr Clin N Am. 1990;37:323-333.
Fenichel GM. Neonatal Neurology. New York, NY: Churchill Livingstone; 1990.
Fernandez J, Saudubray JM, Tada K, eds. Inborn Metabolic Diseases. Diagnosis and Treatment. Berlin: Springer-Verlag; 1990.
Gal P, Oles S, Gilman J et al. Valproic acid efficacy, toxicity, and pharmacokinetics in neonates with intractable seizures. Neurology 1988;341: 467-471.
Harris F. Paediatric Fluid Therapy. Oxford: Blackwell Scientific Publications; 1972:51-54.
Harum K, Hoon A H, Kato G J, et al. Homozygous factor-V mutation as a genetic cause of perinatal thrombosis and cerebral palsy. Develop Med Child Neurol. 1999;41:777-780.
Huang CC, Wang ST, Chang YC, et al. Measurement of urinary lactate:creatinine ratio for early identification of newborn infants at risk for hypoxic-ischemic encephalopathy. N Engl J Med. 1999;341:364-365.
Hyland K, Buist NRM, Powell BR ,et al. Folinic acid responsive seizures: a new syndrome. J Inher Metab Dis. 1995;18:1-5.
Isaacs H. Tumors of the Fetus and the Newborn. Philadelphia, Penn: WB Saunders; 1997.
Jones KL. Smith’s Recognizable Patterns of Human Malformation. Philadelphia, Penn: WB Saunders; 1997.
Kroll JS. Pyridoxine for neonatal seizures: an unexpected danger. Dev. Med. Child. Neurol. 1985;27:377-379.
Levene MI, Lilford RJ, Bennett MJ, et al. Fetal and Neonatal Neurology and Neurosurgery. Edinburgh: Churchill Livingstone; 1995.
Lyon G, Adams RD, Kolodny EH. Neurology of hereditary metabolic diseases in children. New York, NY: McGraw-Hill; 1996.
Lombroso CT. Neonatal EEG polygraphy in normal and abnormal newborns. In: Niedermeyer E, Lopes Da Silva F, eds. Electroencephalography: Basic Principles, Clinical Application, and Related Fields. Baltimore, Md: Williams and Wilkins; 1993.
Painter MJ, Mark MS, Stein AD, et al. Phenobarbital compared with phenytoin for the treatment of neonatal seizures. N Engl J Med. 1999;341:485-489.
Plouin P. Benign neonatal convulsions (familial and non familial). In: Roger J, Dravet C, Bureau FE, et al, eds. Epileptic Syndromes in Infancy, Childhood and Adolescence. London: John Libbey Eurotest; 1985:2-11.
Torres OA, Miller VA, Buist NMR, et al. Folinic acid-responsive neonatal seizures. J Child Neurol. 1999;8:529-532.
Tsang RC. Neonatal magnesium disturbances. Am J Dis Child. 1972;124:282.
Volpe JJ. Neurology of the Newborn. Philadelphia, Penn: WB Saunders; 1997.
Volpe JJ. Neurology of the Newborn. Philadelphia, Penn; WB Saunders Co. 2000.